Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis-Reference-Cited by-同舟云学术

Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis

Published:2019-06-10 Issue:10 Volume:38 Page:2757-2763
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Ogawa Yoshikazu,Takahashi Nobunori,Kaneko Atsushi,Hirano Yuji,Kanayama Yasuhide,Yabe Yuichiro,Oguchi Takeshi,Fujibayashi Takayoshi,Takagi Hideki,Hanabayashi Masahiro,Funahashi Koji,Hayashi Masatoshi,Tsuboi Seiji,Asai Shuji,Asai Nobuyuki,Matsumoto Takuya,Sobue Yasumori,Ishiguro Naoki,Kojima Toshihisa

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-019-04626-x.pdf

Reference30 articles.

1. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an american college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581

2. Suwannalai P, Trouw LA, Toes RE, Huizinga TW (2012) Anti-citrullinated protein antibodies (acpa) in early rheumatoid arthritis. Mod Rheumatol 22:15–20

3. Orr C, Najm A, Biniecka M, McGarry T, Ng CT, Young F, Fearon U, Veale DJ (2017) Synovial immunophenotype and anti-citrullinated peptide antibodies in rheumatoid arthritis patients: relationship to treatment response and radiologic prognosis. Arthritis Rheumatol 69:2114–2123

4. Gottenberg JE, Courvoisier DS, Hernandez MV, Iannone F, Lie E, Canhao H et al (2016) Brief report: association of rheumatoid factor and anti-citrullinated protein antibody positivity with better effectiveness of abatacept: results from the pan-european registry analysis. Arthritis Rheumatol 68:1346–1352

5. Jansen D, Emery P, Smolen JS, Westhovens R, Le Bars M, Connolly SE et al (2018) Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the agree study. RMD Open 4:e000564

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients;Frontiers in Medicine;2024-09-04

2. Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis;Rheumatology;2024-02-06

3. Baseline ANA and Anti‐Ro60/SSA Antibody as Potential Predictors for Immunogenicity and Poor EULAR Response in Adalimumab‐Treated RA Patients;Journal of Clinical Pharmacy and Therapeutics;2024-01

4. Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis;ACR Open Rheumatology;2023-09-29

5. Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post‐hoc analysis of clinical trials;International Journal of Rheumatic Diseases;2023-05-17